Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Intera ...

Find out why a nurse leader is calling for better awareness on the risks of infiltration and extravasation from intravenous ...

Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous HBV)-specific TCR-T therapy, ...

Kanglin Biotech is a China based company, focusing on the research, development and commercialization of first-in-class and best-in-class gene therapy drugs, most of which are targeted at diseases ...

CRISPR gene editing based treatment reduced HAE attacks rates by up to 80%. NTLA-2002 was well tolerated by patients. The ...

The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.

Working with data from the Fred Hutch Cancer Center, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO ...

WRINKLES are a natural part of getting older, but some may reveal more than just your age. Crows feet could be an early ...

The Food and Drug Administration (FDA) has expanded the list of medicines exempted from value-added tax (VAT) to ensure ...